Ovarian Cancer Clinical Trials

Showing 101-120 of 574 trials

COMPLETED

Constitution of ex Vivo Ovarian Tumor Models for the Validation of the Interest of Innovative Therapies and the Search for Tumor or Circulating Biomarkers Predictive of Treatment Response

NCT03831230

Development of ex vivo models of ovarian cancer, fallopian tubes or peritoneum.

Ovarian Cancer

Centre Francois Baclesse250 participantsStarted Mar 2019

Caen, France

ACTIVE_NOT_RECRUITINGPHASE1

A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer

NCT05226507

The purpose of the dose escalation phase is to evaluate the safety profile of escalating doses and dose schedules of NXP800. In the expansion phase the preliminary efficacy in subjects with ARID1a mutated ovarian clear cell and ovarian endometrioid cancers will be estimated.

Advanced Solid TumorOvarian CancerOvarian Clear Cell Carcinoma+5 more

Nuvectis Pharma, Inc.45 participantsStarted Dec 2021

Phoenix, Arizona, United States • La Jolla, California, United States • Aurora, Colorado, United States +19 more locations

Constitution of ex Vivo Ovarian Tumor Models for the Validation of the Interest of Innovative Therapies and the Search for Tumor or Circulating Biomarkers Predictive of Treatment Response

A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer

Related Searches

A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers

Carbon Nanoparticle-Loaded Iron [CNSI-Fe(II)] in the Treatment of Advanced Solid Tumor

Clinical Significance of Germline BRCA Mutations

Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs

ETC-159 In Combination With Pembrolizumab In Advanced MSS/pMMR Ovarian Cancers

Centralization and Oncologic Outcomes in Ovarian Cancer

Study of SYN818 for the Treatment of Advanced or Metastatic Solid Tumors

89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors

Prehabilitation in Ovarian Cancer Patients During Chemiotherapy Before Cytoreductive Surgery.

A Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With Platinum Sensitive Recurrent Ovarian Cancer.

Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery

A Trial of Maintenance Treatment With Fluzoparib Versus Placebo in Relapsed Ovarian Cancer Patients

Expectations and Priorities of Elderly Patients for a First Medical Treatment for Cancer

Short-term Fasting Compared to Free Diet on Ovarian Cancer Patients

Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules

Dose Escalation of Lapatinib With Paclitaxel in Ovarian Cancer

Clinical Impact of Enhanced Risk Assessments in Women With a BRCA1/2 Mutation, CARE Study

A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy